Upregulation of ADAM17 has been shown to contribute to diabetic nephropathy [22,23] and, in an animal model of non-obese, insulin-resistant diabetes blocking of ADAM17 activity restored insulin sensitivity [24]. Here, ADAM17 is linked to diabetic kidney disease.